MDB

At $389.11 and a $31.30 billion market cap, MDB trades at 540.4x trailing EPS, 49.4x forward EPS (on the $7.8726 next-year consensus), 11.26x sales, 10.53x book, and an EV/EBITDA of 1,987.7x. The EV/EBITDA figure is not decision-useful because the EBITDA margin is only 0.50%; it is a mathematical artifact of near-zero EBITDA rather than a valuation signal and should be ignored in favor of cash-flow and revenue multiples. Dividing the 49.4x forward multiple by the roughly 20.3% implied EPS growth from $6.54355 to $7.8726 produces an indicative PEG of about 2.43x, above the 1.5x threshold generally considered attractive for a growth stock; the supplied PEG field is null, so this figure is derived rather than reported. A 1.79% free-cash-flow yield ($561.4 million on a $31.30 billion market cap) sits roughly 320 basis points below the 4.986% risk-free rate, leaving no cash-return cushion, and the 0.0% dividend yield means no shareholder-yield support either. Enterprise value of $27.54 billion is 0.88x market cap, confirming that $2.356 billion of net cash, or 7.53% of market cap, is a meaningful component of equity value. On a sales basis the multiple is less extreme: 11.26x P/S against 30.5% revenue growth implies a P/S-to-growth ratio of roughly 0.37, which is reasonable for a high-gross-margin infrastructure platform. Critically, the October 26 rebound made the stock more expensive on every measure: forward P/E rose from roughly 47.1x, P/S from 10.73x, and the FCF yield fell from 1.88% a run ago. The $452.50 mean target implies 16.3% upside, the $462.50 median 18.9%, the $565.00 high 45.2%, and the $335.00 low only 13.9% downside, a high-to-low spread of $230.00, or 59.1% of the current price. Net: still defensible on revenue growth and net cash, but expensive relative to current cash generation, to a 4.986% risk-free rate, and increasingly so after a 4.86% single-session gain.

The October 26 close of $389.11 is 3.97% above the EMA50 at $374.26, 6.92% above the SMA20 at $363.93, and 9.18% above the EMA200 at $356.40, a decisive improvement on October 23 when the stock closed at $371.09 and the EMA50 was still 0.69% overhead. That single session resolved the medium-term trend question in favor of the bulls and turned the EMA50 from resistance into support. The long-term structure is intact and widening: EMA50 sits $17.86 (5.01%) above EMA200, so the golden-cross configuration holds with no death cross in prospect. The caveat is that the sequence of lower highs since the September 23 peak of $428.36 has not been broken: the October 26 high of $389.88 exceeded the October 22 high of $386.58 but stalled beneath the October 21 close of $390.75 and intraday high of $392.75, so trend characterization remains a volatile basing range between roughly $328 and $393 rather than a confirmed uptrend. Support is the EMA50 at $374.26, the SMA20 at $363.93 and the EMA200 at $356.40; resistance is $392.75, then the October 13 high of $411.49, then $428.36.

For the quarter ended July 31, 2026, EPS was $1.90 versus $1.609 consensus, a $0.29 or 18.1% beat and the largest absolute EPS print in the supplied six-quarter series; no earnings-day share reaction is provided, and the September 28 sell-off followed the CEO departure rather than an earnings miss, while FY27 guidance was reaffirmed on that same day. The average surprise has compressed to roughly 13.9% across the last three quarters (18.1%, 11.5%, 12.1%) from roughly 56.9% across the prior three (66.2%, 52.4%, 52.0%), so the cushion between guidance and delivery is narrowing even as the beat streak continues. Only six quarters are supplied rather than the requested eight, so the beat-rate statistic covers a shorter window than the framework specifies.

The most market-moving item remains CJ Desai's abrupt departure to lead Meta's enterprise AI effort alongside the Meta Enterprise Platform launch. It created an immediate succession problem and simultaneously introduced a well-capitalized competitor into the enterprise software narrative, which is why MDB fell 22.3% pre-market on September 28 and why the stock remains 17.75% below its 52-week high despite reaffirmed FY27 guidance, a proven former CEO back as interim leader, and positive estimate revisions. No article in the bundle is dated after September 29, so a resolution of the permanent CEO search or an escalation from Meta would be the next identifiable swing factor, and the tape rather than a fresh catalyst is currently driving price action.

VIX has fallen 5.45% to 18.39 with the S&P 500 up 0.70%, the Nasdaq up 0.82% and the 10-year yield flat at 4.986%, a benign tape for a 1.748-beta, 49.4x-forward name, but the multiple still needs the 10-year to stay below 5% to avoid re-rating pressure.

MongoDB combines a durable software franchise with a demanding multiple and an unresolved leadership transition, which is the definition of a high-beta growth satellite rather than a core holding. The franchise evidence is real: 30.5% revenue growth, a 72.69% gross margin, $561.4 million of trailing free cash flow, $2.356 billion of net cash equal to 7.53% of the $31.30 billion market cap, six-for-six EPS beats, and 30-day current-year revision breadth of 37 up versus 0 down. The offset is a 49.4x forward multiple, 11.26x sales, a 1.79% free-cash-flow yield against a 4.986% 10-year Treasury, a derived PEG near 2.43x, an operating margin of only 3.68%, an ROE of 1.99% and an ROA of -0.22%. Beta of 1.748, ATR at 6.27% of price, 59.84% 20-day realized volatility and a 17.75% drawdown from the 52-week high of $473.10 mean 15-25% swings are routine rather than exceptional, and the unfilled CEO seat keeps thesis durability at Medium. Size it as a reduced-weight satellite and assume continued very high drawdown risk.